CH
TEVA icon

Cromwell Holdings’s Teva Pharmaceuticals TEVA Stock Holding History

Cromwell Holdings’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$112K Buy
3,319
+943
+40% +$31.4K 0.05% 325
2026
Q1 		$71.6K Hold
2,376
– – 0.04% 399
2025
Q4 		$74.2K Buy
2,376
+185
+8% +$4.56K 0.04% 384
2025
Q3 		$44.3K Buy
2,191
+629
+40% +$11K 0.02% 502
2025
Q2 		$26.2K Buy
1,562
+277
+22% +$4.47K 0.02% 544
2025
Q1 		$19.8K Buy
+1,285
New +$23K 0.01% 559

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Cromwell Holdings's TEVA Position: Q2 2026 in Review

Cromwell Holdings increased its Teva Pharmaceuticals (TEVA) stake by 40% in Q2 2026, buying an estimated $31.4K and bringing the position to 3,319 shares worth $112K. The position accounts for 0.05% of the portfolio, ranked #325.

Cromwell Holdings first reported a position in TEVA in Q1 2025 and has held it in 6 quarters since. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Cromwell Holdings held 3,319 shares of Teva Pharmaceuticals worth $112K as of Q2 2026.
  • Cromwell Holdings bought 943 Teva Pharmaceuticals shares in Q2 2026, an estimated $31.4K.
  • Teva Pharmaceuticals made up 0.05% of Cromwell Holdings's portfolio in Q2 2026, its #325 holding.
  • Cromwell Holdings first reported a position in Teva Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Cromwell Holdings's 13F filing for Q2 2026, filed 14 Jul 2026.